Concepedia

Publication | Closed Access

Antiangiogenic activities and cisplatin-combined antitumor activities of BPR0L075.

12

Citations

36

References

2010

Year

Abstract

BPR0L075 is an antitumoral and antiangiogenic agent and potentiates the anticancer activity of cisplatin.

References

YearCitations

Page 1